GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) 3-Year EBITDA Growth Rate : -3.60% (As of Jun. 2023)

View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria 3-Year EBITDA Growth Rate?

GlaxoSmithKline Consumer Nigeria's EBITDA per Share for the three months ended in Jun. 2023 was ₦0.10.

During the past 12 months, GlaxoSmithKline Consumer Nigeria's average EBITDA Per Share Growth Rate was -36.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -3.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 2.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -13.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of GlaxoSmithKline Consumer Nigeria was 19.50% per year. The lowest was -44.60% per year. And the median was -3.60% per year.

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlaxoSmithKline Consumer Nigeria's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's 3-Year EBITDA Growth Rate falls into.

GlaxoSmithKline Consumer Nigeria 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

GlaxoSmithKline Consumer Nigeria 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA

Website

https://www.ng.gsk.com

GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines